Atlas Trials

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Clinical trial NCT07351045 · RECRUITING

Trial details

NCT number
NCT07351045
Sponsor
Hoffmann-La Roche
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Obesity or Overweight
Start date
2026-03-16
Primary completion
2028-07-24
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.